Summary
Updated Aug 30, 2026
Michelle McMurry-Heath is Director of Bioventus Inc. (BVS). 5 SEC Form 4 filings on record going back to 2025, most recently on 4 June 2026. Most recent open-market trade: sold $105K of BVS on 13 March 2026. Lifetime open-market sales: $295K.
Recent Transactions
6Every recent SEC Form 4 transaction Michelle McMurry-Heath has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Michelle McMurry-Heath. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mark Leonard Singleton - $113K of BVS open-market activity on record
- Anthony D'Adamio - $62K of BVS open-market activity on record
- Katrina J. Church - $36K of BVS open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michelle McMurry-Heath?
Michelle McMurry-Heath is a corporate insider, tracked as Director of Bioventus Inc. (BVS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michelle McMurry-Heath submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michelle McMurry-Heath been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($295K) across all tracked filings.
Where can I see all of Michelle McMurry-Heath's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michelle McMurry-Heath and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
